These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8493040)

  • 1. Clinical aspects of neurolathyrism in Unnao, India.
    Misra UK; Sharma VP; Singh VP
    Paraplegia; 1993 Apr; 31(4):249-54. PubMed ID: 8493040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral and central conduction studies in neurolathyrism.
    Misra UK; Sharma VP
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):572-7. PubMed ID: 8201326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New findings and symptomatic treatment for neurolathyrism, a motor neuron disease occurring in north west Bangladesh.
    Haque A; Hossain M; Khan JK; Kuo YH; Lambein F; De Reuck J
    Paraplegia; 1994 Mar; 32(3):193-5. PubMed ID: 8008424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neurolathyrism, a follow-up study of 200 patients. Part I: Clinical investigation.
    Cohn DF; Streifler M
    Schweiz Arch Neurol Neurochir Psychiatr; 1981; 128(1):151-6. PubMed ID: 7244573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases.
    Ludolph AC; Hugon J; Dwivedi MP; Schaumburg HH; Spencer PS
    Brain; 1987 Feb; 110 ( Pt 1)():149-65. PubMed ID: 3801847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy.
    Ross SA; Engsberg JR
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1114-20. PubMed ID: 17826455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia, and weakness.
    Olgiati R; Burgunder JM; Mumenthaler M
    Arch Phys Med Rehabil; 1988 Oct; 69(10):846-9. PubMed ID: 3178452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of anesthetic blocks for assessment of the spastic patient. A series of 815 motor blocks].
    Filipetti P; Decq P
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):226-38. PubMed ID: 12746697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective tibial neurotomy in the treatment of spastic equinovarus foot in hemiplegic patients: a 2-year longitudinal follow-up of 30 cases.
    Deltombe T; Gustin T
    Arch Phys Med Rehabil; 2010 Jul; 91(7):1025-30. PubMed ID: 20599040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soleus H reflex and motor unit number estimation after tibial nerve block and neurotomy in patients with spastic equinus foot.
    Deltombe T; Jamart J; Hanson P; Gustin T
    Neurophysiol Clin; 2008 Aug; 38(4):227-33. PubMed ID: 18662619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropical spastic paraparesis: a neuroepidemiological study in Colombia.
    Román GC; Román LN; Spencer PS; Schoenberg BS
    Ann Neurol; 1985 Apr; 17(4):361-5. PubMed ID: 4004158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking clinical measurements and kinematic gait patterns of toe-walking using fuzzy decision trees.
    Armand S; Watelain E; Roux E; Mercier M; Lepoutre FX
    Gait Posture; 2007 Mar; 25(3):475-84. PubMed ID: 16837198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Advanced Imaging Methods to Study Neurolathyrism.
    Bick AS; Meiner Z; Gotkine M; Levin N
    Isr Med Assoc J; 2016 Jun; 18(6):341-5. PubMed ID: 27468527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of intrathecal baclofen for spastic hemiparesis following stroke.
    Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L
    Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
    Rousseaux M; Compère S; Launay MJ; Kozlowski O
    J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N; Zucca C; Pecori A
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The motor neuron in chronic neurolathyrism (author's transl)].
    Cohn DF; Streifler M; Schujman E
    Nervenarzt; 1977 Mar; 48(3):127-9. PubMed ID: 854132
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neurological CPC.57. An 80-year-old woman with four years history of muscle atrophy involving lower extremities predominantly on the right side].
    Miwa H; Mori H; Sumino S; Matsuoka S; Shirai T; Imai H; Mizuno Y
    No To Shinkei; 1997 Sep; 49(9):857-65. PubMed ID: 9311007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.